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A collection of 222 isolates of Pseudomonas aeruginosa was obtained from the respiratory tract of 16 patients
with cystic fibrosis over a 4- to 9-month period. Fourteen of these patients were unrelated, while the remaining
two were siblings. Isolates were typed by conventional pyocin typing and also by the use of a DNA probe
containing 741 bp immediately upstream of the exotoxin A structural gene and the initial 732 bp of the exotoxin
A structural gene. By pyocin typing, 69% (11 of 16) of the patients were shown to harbor a single type that
persisted in the lung throughout the study. By genotyping (DNA probe typing), all but three patients (13 of 16,
81%) harbored a single persistent genotype in their lungs. Six patients other than the sibling pair (6 of 14, 43%)
shared a common genotype in their lungs as judged by DNA probing, and the pyocin type of these isolates was
also identical. In four of these six patients, the shared genotype was also the persistent genotype. The sibling
pair studied also carried a common genotype in their lungs as indicated by DNA probing, even though the
pyocin type of these isolates varied. Results presented suggest that the majority of patients harbor a persistent
strain in their lungs and that cross-colonization may occur.
Pseudomonas aeruginosa is the predominant bacterium
associated with pulmonary infection in cystic fibrosis (CF)
patients (6, 29). The organism persists in the airways of CF
patients despite intensive antibiotic therapy and contributes
to pulmonary failure, which is the major cause of morbidity
and mortality in CF patients (9). Strains of P. aeruginosa
colonizing the lung in CF are unique in their sensitivity to
serum (6, 16, 24), presence of rough outer membrane lipo-
polysaccharide (5), ability to polyagglutinate in 0 antisera,
and tendency to produce alginate exopolysaccharide.
Understanding the epidemiology of P. aeruginosa coloni-
zation of the CF respiratory tract has been hampered due to
the predominance of polyagglutinable or nontypeable strains
of P. aeruginosa from CF in conventional 0-antigen sero-
typing reactions (13). Other conventional typing methods
such as phage typing and pyocin typing have poor discrim-
inative powers (18) or poor reproducibility (20), respec-
tively. However, the DNA probe to the upstream region of
the exotoxin A gene developed by Vasil et al. (27) has been
shown to give good discrimination and reproducibility when
used to type P. aeruginosa of CF origin (12).
A probe similar to that used by Ogle et al. (12) was used in
combination with pyocin typing in the present study. Our
results confirm earlier studies (8, 12, 14, 23, 28) that suggest
carriage of a persistent genotype within the lungs of CF
patients. This study also presents results that suggest that
cross- or coinfection may occur in nonrelated patients.
MATERIALS AND METHODS
Patient group. Sixteen children attending the CF clinic,
Royal Children's Hospital, Brisbane, Australia, and ranging
in age from 6 to 19 years were studied. Sputum specimens
were collected from the patients at home following physio-
therapy administered by their parents. Specimens were
collected one or two times every month over a 4- to 9-month
period.
* Corresponding author.
Isolation and identification of P. aeruginosa. Each specimen
was diluted 1:5 in a 1% pancreatin solution, vortexed for 1
min, and incubated at 37°C for 15 to 20 min to allow the
pancreatin to act. Each specimen was again vortexed and
diluted 1:2 to give an initial 1:10 dilution, and further 1:10
dilutions were performed to a final dilution of 10-6. A 100-,ul
portion of each 10-6, 10-5, and 10-4 dilution was plated onto
King A medium (10) supplemented with 200 mg of cetrimide
and 15 mg of nalidixic acid per liter. One of each colony form
present on the isolation plates was picked and purified on a
King A plate. Gram-negative, rod-shaped, cytochrome c
oxidase-positive organisms that utilized glucose oxidatively,
gave a positive arginine dihydrolase reaction, and grew at
41°C were identified as P. aeruginosa. Colony form was
assessed as by Philips (17).
Pyocin typing. For pyocin typing, the method of Fyfe et al.
(2) was used.
DNA extraction. For DNA extraction, the method of
Samadpour et al. (19) was used with some modifications. P.
aeruginosa isolates were grown in 1 ml of Luria broth (11)
shaken in a 5-ml screw-capped tube at 37°C for 18 h. The
bacteria were pelleted in a 1.5-ml microcentrifuge tube in a
Microfuge for 5 to 10 min. The cells were washed in 1 ml of
50 mM Tris hydrochloride (pH 8.0), pelleted, resuspended in
0.7 ml of 50 mM Tris hydrochloride (pH 8.0)-50 mM EDTA
containing 2 mg of lysozyme per ml, and incubated at room
temperature for 10 min. Ten microliters of 20% sodium
dodecyl sulfate and 50 ,ul of 1 mg of pronase E per ml in 10
mM Tris hydrochloride (pH 8.1)-0.2 mM EDTA were added
to each tube, and the tubes were incubated at 37°C for 30
min. Phenol (0.7 ml) saturated with 50 mM Tris hydrochlo-
ride (pH 8.0) was added, and the tubes were shaken vigor-
ously by hand and incubated at 37°C for 30 min with
occasional mixing. The aqueous phase was separated by
centrifuging for 5 min and transferred to a second tube; the
tube was filled with phenol saturated with 50 mM Tris
hydrochloride (pH 8.0) and shaken vigorously by hand. The
aqueous phase was again separated and transferred to a third
tube, chloroform was added to an approximately 1.2-ml total
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FIG. 1. Restriction maps of (A) the ptoxETA plasmid and (B) the pCF1 plasmid prepared by cloning the PstI-BgII fragment of ptoxETA
into the PstI-BamHI sites of pUC19.
volume, and the tubes were then vortexed for 1 min. The
phases were separated by centrifugation for 5 min, the
aqueous phase was transferred to a fourth tube, and 100 RI of
5 M ammonium acetate was added. The tubes were filled
with absolute ethanol, and precipitated DNA was spooled on
a Pasteur pipette, which was allowed to air dry and washed
two to three times in 75% ethanol. Once dry, the DNA was
resuspended in 200 to 400 RI of 10 mM Tris hydrochloride
(pH 8.0)-i mM EDTA depending on the amount of DNA
present.
Probe preparation. The ptoxETA plasmid (3) was kindly
supplied to us by M. L. Vasil, Department of Microbiology
and Immunology, University of Colorado Medical School. A
1,488-bp BglII-PstI fragment of the ptoxETA plasmid con-
taining the 741 bp immediately upstream of the exotoxin A
structural gene (which includes the promoter for the exo-
toxin A gene) and the initial 723 bp of the exotoxin A
structural gene was subcloned into cloning vector pUC19,
forming the new plasmid pCF1. This 1,488-bp fragment
within pCF1 is a modification of the probe of Vasil et al. (27)
in that it includes the U probe and part of the B probe as
designated by those authors (27) (Fig. 1). Both U and B
probes show restriction fragment length polymorphism when
hybridized to restricted P. aeruginosa DNA (27). Plasmid
pCF1 was labelled with biotin-7-dATP by nick translation
and used directly for hybridization. Like the probe used by
Ogle et al. (12), the probe used here revealed restriction
fragment length polymorphism on Southern hybridization,
but due to the longer sequence selected, a greater number of
probe-reactive fragments per isolate were recognized, typi-
cally one or two (Sall and BglII) or one to four (XhoI) unique
fragments for each strain. Upon reading of the results, the
molecular weight of the major probe-reactive fragment was
measured with reference to biotinylated lambda HindIll
molecular weight markers. The major probe-reactive frag-
ment was taken to be the probe-reactive fragment present in
the highest concentration, judged as the darkest fragment
visualized on the blot. This was always equivalent to the
smallest probe-reactive fragment. This is the fragment noted
in Tables 1 and 2. In confirming the genotype, all probe-
reactive fragments were used to deduce the genotype, and in
all cases such an analysis confirmed the genotype as judged
by the use of only the major probe-reactive fragment.
Hence, only the major probe-reactive fragment is noted in
Tables 1 and 2.
Southern blot analysis. Total chromosomal DNA was
digested with the restriction enzymes XhoI, Sall, and BglII,
and each digest was electrophoresed on a 0.7% agarose gel
for approximately 14 h at 30 V. Fragments from the three
digests were transferred to Hybond-N (Amersham) nylon
membrane by the method of Southern (21). The hybridiza-
tion and visualization conditions used were those described
by Samadpour et al. (19). Isolates were considered to
represent the same genotype when the probe-reactive frag-
ments from the three blots were identical in size. Noniden-
tical isolates were defined as those which exhibited different
probe-reactive fragments or those with different total ge-
nomic digestion patterns, as determined on ethidium bro-
mide-stained agarose gels, if the probe-reactive fragments
were of identical size. However, in our work, if the probe-
reactive fragments of isolates were identical, so were the
total genomic digestion patterns.
RESULTS
A Southern hybridization of DNA isolated from selected
strains digested with a single restriction endonuclease, Sall,
is shown in Fig. 2. Sequential isolates from patients 5 (lanes
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FIG. 2. Southern hybridization analysis of restriction digests of
sequential P. aeruginosa isolates digested with Sall and probed with
biotinylated pCF1. Lanes 1 and 15 are biotinylated HindIII-cut
lambda DNA molecular size markers: 23, 9.4, 6.6, 4.4, 2.3, and 2.1
kb, from top to bottom. Lanes 2 and 3 are restricted DNA of
sequential isolates from patient 5; lanes 4 and 5, patient 6; lanes 6 to
8, patient 7; lanes 9 to 12, patient 9; lanes 13 and 14, patient 13. All
lanes show restricted DNA of persistent genotypes of the patient
indicated except lane 12, which contains restricted DNA from a
possible cocolonizing or reinfecting genotype.
2 and 3), 7 (lanes 6 to 8), and 9 (lanes 9 to 11) contained the
same probe-reactive fragment. Patient 9 also harbored an
isolate with a different probe-reactive fragment, as seen in
lane 12. Sequential isolates from patient 6 (lanes 4 and 5)
gave identical probe-reactive fragments, as did those from
patient 13 (lanes 13 and 14). The genotype of these strains
was derived from the size of the major probe-reactive
fragments in Southern hybridization, using chromosomal
DNA digests from three different restriction enzymes. Thus,
the genotype of isolates from patient 3a is 11.3-9.1-7.9 (Table
1) as derived from the size, in kilobases, of the major
probe-reactive fragments after digestion of chromosomal
DNA with XhoI, Sall, and BglII enzymes, respectively.
Tables 1 and 2 summarize the data obtained. When a
pyocin type remained stable over the study period, that is,
when serial isolates from a patient gave the same pyocin
typing result, the genotype in most cases confirmed identity
of the isolates (isolates from patients 5, 11, and 13; Table 1).
For example, 11 isolates of pyocin type 22/e(S3,67) were
isolated from patient 13, and all exhibited a genotype of
9.6-8.0-6.9 (Table 1). However, many isolates identified as
identical by genotype displayed a variable pyocin type, for
example, those from patients 3a and 3b (Tables 1 and 2).
Genotypically identical isolates also exhibited a range of
colony forms (isolates from patients 3a, 3b, 9, 12, 13, 15, 17,
and 18; Tables 1 and 2). For example, isolates with the
genotype 15.5-2.7-7.5 from patient 15 exhibited classic,
mucoid, coliform, and rough colony forms.
Of the 16 patients studied over the 4- to 9-month period, all
but 3 patients (patients 10, 11, and 16) exhibited a single
persistent colonizing genotype (Table 1). A persistent colo-
nizing genotype was defined as one isolated from all or all
but one specimen collected over the study period and
accounting for the majority of isolates from the patient.
However, eight patients (patients 4, 5, 6, 7, 10, 12, 13, and
14; Table 1) showed transient colonization with genotypes
other than the persistent genotype. Transient colonizing
genotypes were defined as those isolated only from one or
two of the specimens collected during the study period. For
example, patient 4 demonstrates a persistent genotype of
6.3-5.6-5.0 isolated from all five specimens obtained and a
transient genotype of 15.5-2.7-7.5 isolated from only one of
the specimens obtained from the patient. Patient 9 carried a
persistent genotype (genotype 6.1-4.1-7.8) but also carried a
recurring genotype (genotype 11.5-8.6-8.2) isolated from
four specimens, suggesting reinfection or cocolonization
(Table 1). Patients 10 and 16 each harbored three genotypes,
none of which was seen to dominate, which may therefore
indicate cocolonization (Table 1).
We studied one sibling pair (patients 3a and 3b; Table 2).
The pyocin type of the 17 isolates of P. aeruginosa collected
over a 7-month period from the sibling pair varied over time.
However, the genotype of the isolates from the siblings
(genotype 11.3-9.1-7.9) did not vary, indicating that the
isolates from both siblings were identical (Table 2).
Of the 14 unrelated patients studied, patients 5, 7, 9, 11,
12, and 16 were found to share identical genotypes within
their lungs (genotype 6.1-4.1-7.8; Table 1). Of these six
patients, patients 5, 7, 9, and 12 harbored this genotype
consistently within their lungs during repeated sampling over
an 8- to 9-month period. Patient 11 was sampled only twice,
and hence any conclusion about persistence cannot be
drawn; patient 16 harbored three distinct genotypes, none of
which was isolated from all specimens. Patient 16 also
harbored a genotype common to patient 15 at times during
the study period. This genotype was also isolated once from
patient 4.
DISCUSSION
Respiratory tracts of CF patients are prone to colonization
with P. aeruginosa (29). Due to the difficulties in typing
isolates of P. aeruginosa from CF patients by conventional
phenotypic typing techniques, the epidemiology of P. aeru-
ginosa infection in CF patients is still not well-defined. We
intensively studied isolates of P. aeruginosa from 16 patients
over a 4- to 9-month period, using phenotypic and genotypic
methods, to see whether the isolates of P. aeruginosa from
individual patients changed over the study period.
Typing of P. aeruginosa isolates of CF origin by conven-
tional phenotypic methods has been found difficult due to
either the mucoid nature or the rough outer membrane of the
isolates. Serotyping, the most commonly used typing
method, gives many polyagglutinable, nonagglutinable, or
autoagglutinable strains (5, 7, 22) and suffers from a lack of
sensitivity (25). Phage typing is not based on stable charac-
teristics, and pyocin type may change due to antibiotic
therapy and changes in bacterial metabolism (25). It is
unknown whether the phenotypic variation observed in P.
aeruginosa isolates judged by such methods is related to any
genotypic variation as determined by restriction fragment
length polymorphism (23). More recently, genetic methods
have been applied to study the epidemiology of P. aerugi-
nosa in CF patients. A probe to the upstream region of the
exotoxin A gene revealing restriction fragment length poly-
morphism in the region downstream of the exotoxin A gene
was discovered by Vasil et al. (27) and has been applied (1,
12, 28) to epidemiological studies of P. aeruginosa isolates.
A similar probe to the pilin genes has also been developed,
but seems to have less discriminatory power when compared
with probes derived from the exotoxin A gene region (23).
Comparison of total genomic digests has also been used (4).
These genotyping methods seem to be more reproducible
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TABLE 1. Summary of typing results of P. aeruginosa isolates derived from all CF patients studied
Time Total no. of No. of Genotype (kb)C No. of Specimens from ColonyPatient (MO)a isolatesb specimens isolates with which genotype morphologye Pyocin typefXh ( Sall Bglll genotype was isolated
3ag 7 8 4 11.3 9.1 7.9*h 8 1-4 M, CL, R Variable
3bg 7 9
4 9 6
5 11.3 9.1 7.9*
5 15.5 2.7 7.5
6.3 5.6 5.0*
5 8 26
6 6 12
7 8 30
9 9 32
12 6.1 4.1 7.8*
8.6 8.6 4.6
3 5.3 3.9 7.4
25.9 9.3 5.0*
11 8.6 8.8 7.3
14.2 2.8 6.9
6.1 4.1 7.8*
11 6.1 4.1 7.8*
11.5 8.6 8.2
24 1-12
2 4, 10
3 1
9 1-3
1 6
1 6
28 1-11
M, CL
M
M, C
C, R
CL
M
CL, M
9/ng(S7)i
1/e(S4.7), 29/ng
3/c
Variable
9/ng(S7)
9/ng(S7)
9/ng(S7)i
27 1-11 CL, M, R 9/ng(S7)' 31/ng(S7)
5 4, 7, 10, 11 C, CL, M 3/k, 3/b
10 8 8
11 4 2
12 9 26
3 11.2 9.5 7.9 1 1
15.0 8.8 9.1 2 2-3
12.7 9.9 8.8 5 2-3
2 6.1 4.1 7.8 2 1-2
12 6.1 4.1 7.8*
10.4 7.8 7.0
6.3 5.4 5.3
24 1-12
1 5
1 11
13 8 13 5 9.6 8.0 6.9*
14.1 9.4 5.2
11 1-5
2 1,3
CL, M, C 22/e(S3,6.7)
CL, C, R 3,e
14 8 4 4 6.2 4.0 8.2
6.3 5.4 5.3*
15 8 14 6 15.5 2.7 7.5* 14 1-6 CL, M, C, R 3/var, 1/var
16 8 10 7 15.5 2.7 7.5 4 1, 2, 3
6.1 4.1 7.8 3 4, 6, 7
8.6 9.4 8.2 4 1,4, 5, 7
17 8 10
18 5 12
4 11.5 9.5 8.5*
3 5.4 3.9 7.2*
10 1-4
12 1-3
CL, M, C, R NG/var
CL, M, C, R 3/var
a Number of months over which specimens were collected.
b Total number of isolates derived from the patient indicated.
Values indicate the size of the major probe-reactive fragment for each of the three blots from DNA digested with the restriction endonuclease indicated. The
resulting pattern is the genotype.
d Each specimen was issued a number in chronological order of sampling; for example, 1-11 indicates that the genotype was isolated from all 11 specimens and
4, 6, 7 indicates that the genotype was isolated from specimens 4, 6, and 7.
e Colony morphology was assessed as by Philips (17): CL, classic; C, coliform; R, rough; M, mucoid.
f Pyocin type was assessed by the spot typing method of Fyfe et al. (2): Variable, total pyocin type exhibited variability in both typing sets; var, second pyocin
indicator set exhibited variability; NG, does not conform to any published type using the first indicator set; ng, does not conform to any published type using the
second indicator set; -, no reaction with the pyocin indicator set.
g Patients 3a and 3b are siblings.
h When a persistent genotype is evident, it is marked by *.
i The untypeable pattern found with the second pyocin typing indicator set with these patients was identical or varied by only a single indicator.
and give greater discrimination in comparison to phenotype
based typing methods. Genotype is therefore a superior
epidemiological marker because the genotype of a strain is a
stable character in comparison to strain type as judged by
nonstable phenotype.
A total of 222 isolates of P. aeruginosa were isolated from
sputum specimens taken from the 16 patients. All isolates
were typed by both a conventional phenotypic method of
typing, pyocin typing, and genotyping, using the pCF1
plasmid probe based on the region of the exotoxin A gene of
P. aeruginosa. Pyocin typing proved a valuable adjunct to
the genotyping technique in this study. All isolates proved to
be typeable, that is, reacted with the pyocin indicator
strains, and isolates from patients with the genotype 6.1-4.1-
9 1-5
1 1
5 1-5
M, CL
M
M
Variable
35/c
Variable
M
M
CL, M
CL, R
CL, M, C, R
R
CL
-lv
1/a, 10/a
-/-, 5/ng
9/ng(S7)
9/ng(S7)
3/n
9/ng(S7)
1 1
3 2-4
M
M
10/a
6/c, 10/var
M
CL, C
M
Variable
9/ng(S7)i
9/ng
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TABLE 2. Typing data on all isolates derived from the sibling pair studied
Date of Genotype (kb)" ColonyPatient Isolate isolation tyb Pyocin typecisolation
~XhoI Sall BglIItyp
3a 61 25/8/87 11.3 9.1 7.9 M NG/v
62 25/8/87 11.3 9.1 7.9 M 26/v
157 20/11/87 11.3 9.1 7.9 M 1/v
158 20/11/87 11.3 9.1 7.9 M NG/-
164 20/11/87 11.3 9.1 7.9 C NG/v
208 5/2/88 11.3 9.1 7.9 M 31/-
267 18/3/88 11.3 9.1 7.9 M NG/v
268 18/3/88 11.3 9.1 7.9 CL NG/v
3b 47 25/8/87 11.3 9.1 7.9 M NG/-
48 25/8/87 11.3 9.1 7.9 M 55/ng
107 8/10/87 11.3 9.1 7.9 M 5/ng
161 20/11/87 11.3 9.1 7.9 M
162 20/11/87 11.3 9.1 7.9 CL
163 20/11/87 11.3 9.1 7.9 M NG/v
216 5/2/88 11.3 9.1 7.9 M 49/c
251 18/3/88 11.3 9.1 7.9 M NG/ng(S8)
252 18/3/88 11.3 9.1 7.9 M NG/ng(S5.8)
a Values indicate size of the major probe-reactive fragment for each of the three blots from DNA digested using the restriction endonuclease indicated. The
resulting pattern is the genotype.
b Colony morphology was assessed as by Philips (17): CL, classic; C, coliform; R, rough; M, mucoid.
c Pyocin type was assessed by the spot typing method of Fyfe et al. (2): NG, does not conform to any published pyocin type using the first indicator set; ng,
does not conform to any published pyocin type using the second indicator set; -, no reaction with the pyocin indicator set.
7.8 proved to give an identical pyocin type [9/ng(S7)].
However, with pyocin typing alone, the relationship of serial
isolates from many patients became confused, with pyocin
type indicating dissimilarity of isolates which were shown to
be identical by genotyping. The intensive antibiotic therapy
commonly used to treat pulmonary exacerbations may ex-
plain this variability in pyocin type (25).
Most recent research suggests that, once one strain colo-
nizes the lung of the CF patient, this strain remains the
dominant strain within the lung, and changes in the strain
type are very rare (8, 12, 14, 23, 28). The results we obtained
support this. As judged by the DNA probe, all but one
patient studied exhibited a remarkably constant P. aerugi-
nosa flora within their lungs, with one genotype predominat-
ing and only occasional transient genotypes being present;
only two patients (patients 10 and 16) showed any marked
variability in genotype composition of their sputum. How-
ever, both Speert et al. (23) and Wolz et al. (28) suggest that
changes may occur in the persistent colonizing genotype.
Speert and coworkers studied a group of 23 patients over a
7-year period, using a pilin gene probe, and discovered that
in 43.5% (10 of 23) of patients a change in the persistent
colonizing genotype occurred. Wolz and coworkers (28)
found that, in 43% (12 of 32) of patients over a 6-month
period, a change in the P. aeruginosa genotype or strain loss
was found. The absence of any patient exhibiting a change in
the persistent colonizing genotype in this study may be due
to the limited time course or the limited patient group
studied.
The sibling pair studied harbored an identical, persistently
colonizing genotype within their lungs, indicating a high
probability of cross-colonization. Grothues et al. (4) used
pulse-field gel electrophoresis of the whole P. aeruginosa
chromosome in a genome fingerprinting technique to geno-
type isolates of P. aeruginosa from 22 siblings from eight
families. They reported that colonization with identical or
closely related genotypes is common. Wolz et al. (28), using
a probe similar to that used in this study, reported that
siblings predominantly harbor identical genotypes within
their lungs. Ogle et al. (12a) reported that, over a 4- to 6-year
period, two siblings remained nearly constantly colonized
with the same persistent genotype. Cocolonizing genotypes
were also found in the sibling pair studied by Ogle et al.
(12a), similar to the possible cocolonizing genotype found in
patient 9 in this study. From 4 of the 11 sampling occasions
of patient 9, a genotype other than the persistent genotype
was found. Frequency of reisolation of this genotype sug-
gests reinfection or cocolonization with this genotype.
The question of cross-colonization in CF patients has not
been conclusively resolved. H0iby and Rosendal in 1980 (7)
described the presence of a dominant strain in Denmark,
using serotyping and phage typing as the typing methods.
These authors suggested a possible cross-infection with the
endemic serotype in the CF treatment center. The same
clinic was still experiencing colonization and possible cross-
infection with this endemic serotype in 1983 (30). This
serotype became resistant to the antibiotics commonly used
to treat CF patients (15). Isolation of patients with this
endemic serotype seemed to stop further spread. Speert and
Campbell in 1987 (22), using serotyping to type P. aerugi-
nosa isolates, concluded that transient cross-colonization
occurred between pairs of patients, but.the cross-colonizing
serotype had usually disappeared from subsequent speci-
mens. However, due to the inadequacies of serotyping and
phage typing, interpretation of these results is difficult.
Grothues et al. (4), using genome fingerprinting, found no
cross-colonization between unrelated patients and con-
cluded that cross-colonization is rare unless contact is pro-
longed or intimate. However, Wolz et al. (.8), using a DNA
probe technique, suggested that cross-colonization of pa-
tients occurred at home and in the clinic studied. Data
presented here support possible cross-colonization of pa-
tients. Twenty-five percent (4 of 16, patients 5, 7, 9, and 12;
Table 1) of patients harbored the same persistent genotype,
which exhibited the same pyocin type, 9/ng(S7). Also, one
patient (patient 11) from whom only two isolates were typed
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harbored this genotype, and another patient (patient 16) in
whom the genotype composition of the sputum varied also
harbored the same genotype. Neither of these patients,
however, appeared to harbor this genotype as a persistent
genotype. Therefore, it is possible that at some time in the
past contact between these patients allowed cross-coloniza-
tion.
A further explanation of the predilection of the 6.1-4.1-7.8
genotype for the CF lung may be that this genotype may
outcompete other genotypes within the lung environment. It
has been hypothesized that the high incidence of uncommon
pyocin types may be related to an enhanced ability of these
P. aeruginosa pyocin types to colonize the lung (26). One
such uncommon pyocin type, 9ng(S7), has been correlated
with a persistent genotype isolated from four unrelated
patients.
In conclusion, the phenotypically based pyocin typing
method used in this study showed too great a variability in
comparison to the genotypic typing method to be used as the
only typing method in epidemiological investigations. How-
ever, when used in combination with genotypic methods,
pyocin typing may provide valuable supplementary informa-
tion to support genotypic epidemiological evidence.
Data presented here support previous investigations into
the epidemiology of isolates of P. aeruginosa from the CF
lung. Serial specimens from patients showed one persistent
colonizing genotype of P. aeruginosa, and the sibling pair
studied harbored an identical genotype of P. aeruginosa in
their lungs. Results suggest that cross-colonization or cocol-
onization of some of the CF patients studied may have taken
place, and possible environmental sources for such a strain
are being investigated.
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